Several other analysts also recently weighed in on PAHC. Morgan Stanley cut their price target on Phibro Animal Health from $18.00 to $17.00 and set an “equal weight” rating on the stock in a research note on Thursday. Roth Mkm reaffirmed a “buy” rating and issued a $21.00 target price on shares of Phibro Animal Health in a report on Tuesday. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $18.25.
Phibro Animal Health Stock Performance
Phibro Animal Health (NASDAQ:PAHC – Get Free Report) last posted its quarterly earnings data on Thursday, August 31st. The company reported $0.38 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.02). Phibro Animal Health had a return on equity of 18.13% and a net margin of 2.92%. The firm had revenue of $255.00 million during the quarter, compared to analysts’ expectations of $256.68 million. During the same quarter in the previous year, the company posted $0.36 earnings per share. On average, equities research analysts forecast that Phibro Animal Health will post 1.23 EPS for the current year.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of the company. Comerica Bank acquired a new position in shares of Phibro Animal Health during the 2nd quarter worth about $3,877,000. Alliancebernstein L.P. raised its position in shares of Phibro Animal Health by 3.4% during the 2nd quarter. Alliancebernstein L.P. now owns 26,630 shares of the company’s stock valued at $365,000 after buying an additional 880 shares during the period. Wells Fargo & Company MN raised its position in shares of Phibro Animal Health by 1.0% during the 2nd quarter. Wells Fargo & Company MN now owns 206,345 shares of the company’s stock valued at $2,827,000 after buying an additional 2,041 shares during the period. Connors Investor Services Inc. raised its position in shares of Phibro Animal Health by 15.3% during the 2nd quarter. Connors Investor Services Inc. now owns 15,101 shares of the company’s stock valued at $207,000 after buying an additional 2,000 shares during the period. Finally, Royal Bank of Canada increased its holdings in Phibro Animal Health by 8.8% in the 2nd quarter. Royal Bank of Canada now owns 9,188 shares of the company’s stock valued at $127,000 after purchasing an additional 745 shares during the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
- Five stocks we like better than Phibro Animal Health
- Investing in Travel Stocks Benefits
- 2 Stocks That Doubled EPS Estimates and Flashing Buy Signals
- NYSE Stocks Give Investors a Variety of Quality Options
- Toyota vs Tesla: The Tortoise And The Hare Race Has A New Meaning
- Insider Trades May Not Tell You What You Think
- 5 Critical Takeaways From MongoDB’s Q2 Results for AI Investors
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.